Dana-Farber/Brigham and Women’s Cancer Center (Boston). Dana-Farber/Brigham and Women’s Cancer Center is a collaboration of the Dana-Farber Cancer Institute and Brigham and Women’s Hospital created to ...

Dana-Farber Cancer Institute has made its first official pitch to state regulators about its planned 300-bed freestanding hospital, saying the project will increase competition and is necessary to ...

The head of Dana-Farber Cancer Institute has announced her plans to step down, as her successor has been appointed to lead the world-renowned cancer center. Laurie Glimcher will step down as president ...

Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) has the following research output in the current window (1 August 2024 - 31 July 2025) of the Nature Index. Click on Count to view a list of ...

Dana-Farber Cancer Institute has agreed to pay $15 million to settle federal allegations tied to research grants meant to support lifesaving work. Federal officials say the Boston-based cancer center ...

BOSTON, May 22, 2025 – Dana-Farber Cancer Institute researchers are leading four studies with compelling and potentially practice changing results in colorectal cancer and breast cancer. Investigators ...

Please provide your email address to receive an email when new articles are posted on . Dana-Farber Cancer Institute and Boston Children’s Cancer and Blood Disorders Center have received a 4-year, $5 ...

Allegations of research misconduct at Dana-Farber Cancer Institute have stirred discussions about scientific integrity and the pivotal role of amateur sleuths in identifying image manipulation in ...

See this story in STAT. A review of alleged data manipulation in studies involving four top scientists at Dana-Farber Cancer Institute has led to plans to retract six papers and correct 31 manuscripts ...

Dana-Farber Cancer Institute president and CEO Dr. Laurie H. Glimcher has announced she will step down on October 1 and assume the title of president emerita. Dr. Benjamin Levine Ebert, chair of the ...

Dana-Farber Cancer Institute has agreed to pay $15 million to resolve claims that the Harvard Medical School affiliate wrongly used National Institutes of Health grant funding to support the ...